2Iseki K. Body mass index and the risk of chronic renal failure:the Asian experience [ J ]. Contributions to Nephrology, 2006, 151 : 42-56.
3Chen HM, Liu ZH, Zeng CH, et al. Podoeyte lesions in patients with obesity-related glomerulopathy [ J ]. Am J Kidney Dis, 2006, 48:772-779.
4Pavkov ME, Knowler WC, Bennett PH, et al. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians [ J ]. Kidney Intern,2006,70 : 1840-1846.
5Pistrosch F, Herbrig K, Kindel B, et al. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients [ J]. Diabetes ,2005,54:2206-2211.
6Darren J, Jackie H, Sauro V, et al. Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway [ J ]. Kidney Int ,2005,67 : 1308-1314.
7Anderson PW,Zhang XY,Tian J,et al. Insulin and angiotensin Ⅱ are additive in stimulating TGF-beta1 and matrix mRNAs in mesangial cells[ J ]. Kidney Int, 1996,50:745-753.
8Blendea MC, Jacobs D, Stump CS, et al. Abrogation of oxidative stross improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin Ⅱ overexpression[ J]. Am J Physiol Endocrinol Metal, 2005,288 : E353-E359.
1Weyer C,Bogardus C,Mott DM,et al.The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.J Clin Invest,1999;104(6):787.
2Dresner A,Laurent D,Marcucci M,et al.Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-Kinase activity. J Clin Invest,1999;103(2):253.
3Nagi DK,Knowler WC,Mohamed AV, et al. Intact proinsulin, des31,32 proinsulin, and specific insulin concentrations among no diabetic and diabetic subjects in populations at varying risk of type 2 diabetes. Diabetes Care, 1998;21(1):127.
4Shiraishi I, Iwamoto Y, Kuzuya T, et al. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.Diabetologia,1991;34(10):737.
5Yoshikawa H,Tajiri Y,Sako Y, et al.Effect of free acides on βcell functions:a possible involvement of peroxisome proliferatoractivated receptorsαor pancreatic/duodenal homeobox. Metabolism,2001;50(2):613.
6Magnan C,Collin S,Berthault MF, et al.Lipid infusion lowers sympathetic nervous activity and leads to increased β cell responsiveness to glucose.J Clin Invest,1999;103(3):413.
7Maddux BA, See W, Lawrence JC Jr, et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes,2001,50 ( 2 ) :404410.
8Steppan CM,Bailey ST,Bhat S,et al. The hormone resistin links obesity to diabetes. Nature,2001,409 (6818) :307-312.
9Evans JL, Goldfine ID. α-Lipoic acid:a multi-functional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther,2000,2(3) :401-413.
10Fukuzawa Y,Watanabe Y,Inaguna D,et al.Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state.J Lab Clin Med,1996,128:568-578.
